Pitfalls in quantitative myocardial PET perfusion I: Myocardial partial volume correction

J Nucl Cardiol. 2020 Apr;27(2):386-396. doi: 10.1007/s12350-020-02073-9. Epub 2020 Feb 24.

Abstract

Background: PET quantitative myocardial perfusion requires correction for partial volume loss due to one-dimensional LV wall thickness smaller than scanner resolution.

Methods: We aimed to assess accuracy of risk stratification for death, MI, or revascularization after PET using partial volume corrections derived from two-dimensional ACR and three-dimensional NEMA phantoms for 3987 diagnostic rest-stress perfusion PETs and 187 MACE events. NEMA, ACR, and Tree phantoms were imaged with Rb-82 or F-18 for size-dependent partial volume loss. Perfusion and Coronary Flow Capacity were recalculated using different ACR- and NEMA-derived partial volume corrections compared by Kolmogorov-Smirnov statistics to standard perfusion metrics with established correlations with MACE.

Results: Partial volume corrections based on two-dimensional ACR rods (two equal radii) and three-dimensional NEMA spheres (three equal radii) over estimate partial volume corrections, quantitative perfusion, and Coronary Flow Capacity by 50% to 150% over perfusion metrics with one-dimensional partial volume correction, thereby substantially impairing correct risk stratification.

Conclusions: ACR (2-dimensional) and NEMA (3-dimensional) phantoms overestimate partial volume corrections for 1-dimensional LV wall thickness and myocardial perfusion that are corrected with a simple equation that correlates with MACE for optimal risk stratification applicable to most PET-CT scanners for quantifying myocardial perfusion.

Keywords: ACR or NEMA PET phantoms; Cardiac positron emission tomography (PET); coronary flow reserve; partial volume correction; quantitative myocardial perfusion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiology / standards*
  • Fluorodeoxyglucose F18
  • Heart / diagnostic imaging*
  • Heart Ventricles / diagnostic imaging*
  • Humans
  • Myocardial Perfusion Imaging
  • Myocardium / pathology
  • Perfusion
  • Phantoms, Imaging
  • Positron Emission Tomography Computed Tomography
  • Positron-Emission Tomography / methods*
  • Reproducibility of Results
  • Risk
  • Rubidium Radioisotopes

Substances

  • Rubidium Radioisotopes
  • Fluorodeoxyglucose F18
  • Rubidium-82